Combination therapy may offer better outcomes for patients with retinoblastoma

Targeting survivin — a protein that inhibits apoptosis or cell death — enhances the effectiveness of chemotherapy in cells and mouse models of retinoblastoma (Rb), the most common malignant tumor of the eye in children, researchers report.